47
SCHOENHAGEN P, VINCE DG, ZIADA KM, KAPADIA SR, LAUER MA, CROWE TD,
NISSEN SE, TUZCU EM. Relation of matrix-metalloproteinase 3 found in coronary
lesion samples retrieved by directional coronary atherectomy to intravascular
ultrasound observations on coronary remodeling. Am J Cardiol. 89:1354-9, 2002.
SCHONBECK U, MACH F, SUKHOVA GK, ATKINSON E, LEVESQUE E, HERMAN M,
GRABER P, BASSET P, LIBBY P. Expression of stromelysin-3 in atherosclerotic
lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med.
189:843-53, 1999.
SHAPIRO SD. Diverse roles of macrophage matrix metalloproteinases in tissue
destruction and tumor growth. Thromb Haemost. 82:846-9, 1999.
SHIMOKATA K, YAMADA Y, KONDO T, ICHIHARA S, IZAWA H, NAGATA K,
MUROHARA T,OHNO M, YOKOTA M. Association of gene polymorphisms with
coronary artery disease in individuals with or without nonfamilial
hypercholesterolemia. Atherosclerosis. 172:167-73, 2004.
SIWIK DA, CHANG DL, COLUCCI WS. Interleukin-1beta and tumor necrosis factor-
alpha decrease collagen synthesis and increase matrix metalloproteinase activity in
cardiac fibroblasts in vitro. Circ Res. 86:1259-65, 2000.
SILENCE J, COLLEN D, LIJNEN HR. Reduced atherosclerotic plaque but enhanced
aneurysm formation in mice with inactivation of the tissue inhibitor of
metalloproteinase-1 (TIMP-1) gene. Circ Res. 90:897-903, 2002.
SILENCE J, LUPU F, COLLEN D, LIJNEN HR. Persistence of atherosclerotic plaque but
reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation.
Arterioscler Thromb Vasc Biol. 21:1440-5, 2001.
SUKHOVA GK, SCHONBECK U, RABKIN E, SCHOEN FJ, POOLE AR,
BILLINGHURST RC, LIBBY P. Evidence for increased collagenolysis by interstitial
collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation.
99:2503-9, 1999.
TERASHIMA M, AKITA H, KANAZAWA K, INOUE N, YAMADA S, ITO K, MATSUDA
Y, TAKAI E, IWAI C, KUROGANE H, YOSHIDA Y, YOKOYAMA M. Stromelysin
promoter 5A/6A polymorphism is associated with acute myocardial infarction.
Circulation. 99:2717-9, 1999.
TSUKIOKA K, SUZUKI J, FUJIMORI M, WADA Y, YAMAURA K, ITO K, MORISHITA
R, KANEDA Y,ISOBE M, AMANO J. Expression of matrix metalloproteinases in
cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene
transfection. Cardiovasc Res. 56:472-8, 2002.
UEMURA S, MATSUSHITA H, LI W, GLASSFORD AJ, ASAGAMI T, LEE KH,
HARRISON DG, TSAO PS. Diabetes mellitus enhances vascular matrix
metalloproteinase activity: role of oxidative stress. Circ Res. 88:1291-8, 2001.
WAGNER S, KLUGE B, KOZIOL JA, GRAU AJ, GROND-GINSBACH C. MMP-9
polymorphisms are not associated with spontaneous cervical artery dissection.
Stroke. 35:e62-4, 2004.